2028年までのアジア太平洋地域の血尿治療市場予測 – 新型コロナウイルス感染症の影響と治療(薬剤、治療法、その他)、適応症(尿路感染症、腎臓結石、尿道炎、血液がん、膀胱結石、前立腺がん、膀胱炎、外傷)別の地域分析、激しい運動、多発性嚢胞腎、子宮内膜症、月経)、タイプ(肉眼的血尿、顕微鏡的血尿、特発性血尿、ジョガー血尿)、エンドユーザー(病院、診療所、外来手術センターなど)

TIPRE00026249 | Pages: 181 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

市場紹介

血尿は、尿中に血液が認められる病状です。 。一般に、尿には赤血球が含まれていないため、腎臓結石、尿路感染症、その他の遺伝性疾患を引き起こす可能性のある深刻な問題が発生する可能性があります。

さらに、血尿の有病率が高いため、関連する兆候は、予測期間中に市場の成長を促進すると予想されます。しかし、関連する適応症の未診断の症例がアジア太平洋地域の血尿治療市場の成長を制限しています。

新型コロナウイルス感染症(COVID-19)の流行は観光産業に深刻な影響を及ぼし、サプライチェーンに混乱をもたらしています。さらに、低所得国は医療インフラの不足によりさらなる課題に直面しています。韓国、マレーシア、シンガポール、フィリピン、インドでは、病気の伝播を防ぐために制限措置が講じられています。これらすべての要因は、サプライチェーンの制限と製造能力の限界により、短期間、血尿治療市場に中程度の影響を与えました。新型コロナウイルス感染症患者における腎臓の関与は、血尿、タンパク尿、膿尿、急性腎障害(AKI)などの幅広い症状を引き起こす可能性があります。タンパク尿と血尿は、AKI よりも COVID 19 の有病率が高いことが報告されています。一方、AKIは現在、入院中の新型コロナウイルス感染症患者にとって憂慮すべき兆候であり、死亡の主要な危険因子となっている。したがって、血尿治療市場は新型コロナウイルス感染症 19 の影響を受けています。

市場の概要とダイナミクス

アジア太平洋地域の血尿治療市場は、2021年の2億1,100万米ドルから2028年までに2億5,760万米ドルに達すると予測されています。 2021 年から 2028 年までに 2.9% の CAGR で成長すると予想されています。慢性適応症の有病率の上昇により、医療支出は大幅に増加しています。さまざまな国の政府は、医療インフラの改善に多額の投資を行っています。さらに、先進国の患者は、血尿治療の可能な治療法と償還の利用可能性について認識し始めています。血尿は、血液がん、膀胱がん、腎臓がんなどの慢性疾患の初期症状の 1 つです。これらの病気はさまざまな健康保険でカバーされており、患者の治療が容易になり、医療の経済的負担が軽減されます。したがって、医療支出と治療に対する患者の意識の向上が、アジア太平洋地域の血尿治療市場を牽引しています。

主要市場セグメント

2020 年のアジア太平洋地域の血尿治療市場では、種類別に肉眼的血尿セグメントが最大のシェアを占めました。治療に関しては医薬品セグメントが占めました。適応症に関しては、尿路感染症セグメントが2020年のアジア太平洋血尿治療市場で最大のシェアを占めました。エンドユーザーに関しては、病院セグメントが占めました。 2020 年のアジア太平洋地域の血尿治療市場で最大のシェア。

リストされている主要な供給源と企業

アジア太平洋地域の血尿治療市場に関するこのレポートを作成するために参照したいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府の文書、統計データベースです。その他。報告書に記載されている主要企業は、アストラゼネカ、ブリストル・マイヤーズ スクイブ社、F. ホフマン・ラ・ロッシュ社、グラクソ・スミスクライン社、ヤンセン・ファーマシューティカルズ社、メルク・アンド・ヘルスケア社などです。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd、および Boehringer Ingelheim International GmbH。

レポートを購入する理由

  • アジア太平洋地域の血尿治療市場の状況を理解し、市場セグメントを特定するため高い収益が保証される可能性が高い
  • 絶えず変化する市場環境を理解し、競争で優位に立つため
  • 最も売上が見込めるセグメントを特定することで、アジア太平洋地域の血尿治療市場における合併・買収および提携取引を効率的に計画する
  • 洞察力のある包括的な分析から、知識に基づいたビジネス上の意思決定を行う。さまざまなセグメントの市場パフォーマンス
  • 2021年から2028年の期間のさまざまなセグメントに基づいたアジア太平洋地域の血尿治療市場の市場収益予測を取得するため

アジア太平洋血尿治療市場セグメンテーション

作成者 治療

  • 薬物
  • 療法
  • その他

適応症別

  • 尿路感染症
  • 腎臓結石
  • 尿道炎
  • 血液がん
  • 膀胱結石
  • 前立腺がん
  • 膀胱炎
  • 外傷
  • 激しい運動
  • 多発性嚢胞腎
  • 子宮内膜症
  • 月経

タイプ別

  • 肉眼的血尿
  • 顕微鏡的血尿
  • 特発性血尿
  • ジョガーの血尿

エンド ユーザー別

  • 病院
  • クリニック
  • 外来手術センター(ASC の)
  • その他

国別

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他のアジア太平洋地域

記載されている企業

  1. アストラゼネカ
  2. ブリストル マイヤーズ スクイブ カンパニー
  3. F.ホフマン・ラ・ロッシュ株式会社
  4. グラクソ・スミスクライン plc.
  5. ヤンセン・ファーマシューティカルズ
  6. メルク&メルク社株式会社
  7. ノバルティス AG
  8. ファイザー株式会社
  9. < span>サンファーマシューティカルインダストリーズ株式会社
  10. ベーリンガーインゲルハイムインターナショナルGmbH

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Hematuria Treatment Market – By Treatment

1.3.2        Asia Pacific Hematuria Treatment Market – By Indication

1.3.3        Asia Pacific Hematuria Treatment Market – By Type

1.3.4        Asia Pacific Hematuria Treatment Market – By End User

1.3.5        Asia Pacific Hematuria Treatment Market – By Country

2.           Asia Pacific Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – Asia Pacific Analysis

6.1         Asia Pacific Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         Asia Pacific Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        Asia Pacific Hematuria Treatment Market – Geographic Analysis

11.1      Asia Pacific: Hematuria Treatment Market

11.1.1     Overview

11.1.2     Asia Pacific: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3     Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.4     Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.5     Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.6     Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7     Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

11.1.7.1       China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1       China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2       China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3       China: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.1.4       China: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.1.5       China: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.2       Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1       Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2       Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3       Japan: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.2.4       Japan: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.2.5       Japan: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.3       India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1       India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2       India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3       India: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.3.4       India: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.3.5       India: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.4       South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1       South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.2       South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.3       South Korea: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.4.4       South Korea: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.4.5       South Korea: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.5       Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.1       Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.2       Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.3       Australia: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.5.4       Australia: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.5.5       Australia: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.6       Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.1       Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.2       Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.3       Rest of Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.6.4       Rest of Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.6.5       Rest of Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 7.             China: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Japan: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 14.          India: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 15.          India: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          India: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 18.          South Korea: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 19.          South Korea: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Australia: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Australia: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Australia: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Rest of Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Organic Developments Done by Companies

Table 30.          Inorganic Developments Done by Companies

Table 31.          Glossary of Terms, Hematuria Treatment Market

 


LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           Asia Pacific Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           India to Show Significant Growth During Forecast Period

Figure 5.           Asia Pacific Hematuria Treatment Market, Industry Landscape

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           Asia Pacific Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        Asia Pacific Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        Asia Pacific: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 37.        Asia Pacific: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

Figure 39.        China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Impact Of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 46.          Growth Strategies Done by the Companies in the Market, (%)
  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific hematuria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000